James M. Daly, Director at HALOZYME THERAPEUTICS, INC. (HALO), sold 68,674 shares at $29.12 ($2.0M) on 2020-08-13, disclosed to the SEC on 2020-08-13.
Open-market sale of $2.0M HALO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.12 | 34,337 | $1000K | 50.0% |
| 2 | $29.12 | 34,337 | $1000K | 50.0% |
| Total | $29.12 avg | 68,674 | $2.0M | 100% |
| Filing → |
| MDGL | SELL | 2024-04-03 | $15.9M | — | Filing → |
| HALO | SELL | 2023-08-15 | $875K | — | Filing → |
| HALO | SELL | 2020-11-25 | $838K | — | Filing → |